What is incidence of malignant hypehermia in pediatric patients-
**Core Concept**
Malignant hyperthermia (MH) is a rare but life-threatening medical emergency that occurs in response to certain anesthetic agents, particularly volatile anesthetics and succinylcholine. It is characterized by a rapid rise in body temperature, muscle rigidity, and metabolic acidosis.
**Why the Correct Answer is Right**
Malignant hyperthermia is caused by an abnormality in the ryanodine receptor type 1 (RyR1) gene, leading to an excessive release of calcium ions from the sarcoplasmic reticulum. This results in a cascade of events that ultimately lead to muscle rigidity, hyperthermia, and metabolic acidosis. The incidence of malignant hyperthermia in pediatric patients is estimated to be around 1 in 50,000 to 1 in 200,000.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because the incidence of malignant hyperthermia is not as high as 1 in 10,000, which would be a significant public health concern.
**Option B:** This option is incorrect because the incidence of malignant hyperthermia in pediatric patients is not as low as 1 in 1,000,000, which would make it an extremely rare condition.
**Option C:** This option is incorrect because the incidence of malignant hyperthermia in pediatric patients is not as high as 1 in 1,000, which would be a significant risk factor for anesthesiologists.
**Clinical Pearl / High-Yield Fact**
Malignant hyperthermia is often triggered by the use of halothane or isoflurane, and can be prevented by the use of dantrolene, a specific antidote that inhibits the release of calcium ions from the sarcoplasmic reticulum.
**Correct Answer:** .